POSTER SESSION B-04: Prediction and Prognostic Models
Tracks
POSTER AREA (M1 building upper floor)
Wednesday, July 24, 2024 |
9:00 AM - 5:00 PM |
POSTER AREA (M1 building upper floor) |
Presentations
Mr. Lasai Barreñada
KU Leuven, Belgium
P-B04-01 | Multicentre flexible calibration curves with binary outcomes using random effects meta-analysis
Ms. Mae Chester-Jones
DPhil Clinical Epidemiology And Biostatistics
University of Oxford, United Kingdom
P-B04-02 | Maternal Early Warning Scores for detecting deterioration in women during pregnancy: A systematic review
Mr. Gordon Forbes
King's College London, United Kingdom
P-B04-03 | Accounting for between-study heterogeneity when developing prediction models using IPD meta-analysis: A comparison of methods and recommendations for practice
Ms. Amy Magona
Biostatistician
Primary Care Clinical Trials Unit, University of Oxford, United Kingdom
P-B04-04 | Prediction performance effect of added-value biomarkers in multivariable heart failure prognostic models: A systematic review
Mr. Giuseppe Occhino
Strategic Regional Agency for Health and Social Care of Apulia (AReSS Puglia), Bari, Italy
P-B04-05 | Prognostic models for heart failure progression: Systematic review and meta-analysis
Ms. Jyoti Sehjal
PhD Student
University of Oxford, United Kingdom
P-B04-06 | Prediction models for prognostic outcomes in myelodysplastic syndromes and acute myeloid leukaemia: A systematic review
Prof. Gareth Ambler
University College London, United Kingdom
P-B04-07 | A sample size calculation for developing a risk prediction model for a binary outcome
Dr. Menelaos Pavlou
Associate Professor
University College London, United Kingdom
P-B04-08 | How to improve model stability when calculating the sample size and accuracy when estimating a prediction model
Prof. Donna Ankerst
Technical University of Munich, Germany
P-B04-09 | Selection and verification bias adjustments for clinical risk model validation
Mr. Frank Doornkamp
Leiden UMC, Netherlands
P-B04-10 | Integrating genomic markers for enhanced prediction: Uncertainty assessment of clinical usefulness in early breast cancer
Prof. Evangelos Kritsotakis
Associate Professor of Biostatistics
University of Crete, Heraklion, Greece
P-B04-11 | Statistical pitfalls and errors in external validation studies of clinical prediction models: A case study with the SAPS II and SAPS 3 prognostic models for critically ill patients
Mr. Yanakan Logeswaran
PhD Student
King's College London, United Kingdom
P-B04-12 | Examining model stability across modelling approaches to predicting poor functioning for individuals at-risk of psychosis
Dr. Ewan Carr
King’s College London, United Kingdom
P-B04-13 | Development and validation of a novel longitudinal prognostic model for depressive relapse using passively measured biomarkers
Dr. Ryo Emoto
Nagoya Graduate School of Medicine, Japan
P-B04-14 | Development and validation of treatment effect functions in observational studies: Application to predictive analysis of amiodarone in out-of-hospital cardiac arrest patients
Ms. Shan Gao
KU Leuven, Belgium
P-B04-15 | A comparison of regression models for static and dynamic prediction in electronic health records in the absence of censoring
Dr. Tommi Härkänen
Research Manager
Finnish Institute for Health and Welfare (THL), Helsinki, FInland
P-B04-16 | Diagnostic tool to assess projected occupation probabilities in illness-death model
Dr. Joyce (Yun-Ting) Huang
Research Associate
University of Manchester, United Kingdom
P-B04-17 | Quantifying the impact of underdiagnosis in outcome data when developing and validating a clinical prediction model: A simulation study
Dr. Seyed Amirhossein Jalali
University of Limerick, Ireland
P-B04-18 | Prognosis value of immunocyte ratios in neoadjuvant chemotherapy-treated breast cancer
Dr. David Jenkins
University of Manchester, United Kingdom
P-B04-19 | Use of statistical process control to monitor calibration-in-the-large of a clinical prediction model
Ms. Carolien Maas
Erasmus MC, Rotterdam, Netherlands
P-B04-20 | Predicting individualised treatment effects: A comparison of different modelling approaches and performance metrics
Mr. Ryunosuke Machida
National Cancer Center, Tokyo, Japan
P-B04-21 | Predicting study duration based on dynamic predictions using joint models in clinical trials with a time-to-event endpoint
Dr. Roberto Melotti
Eurac Research, Bolzano/Bozen, Italy
P-B04-22 | Tremor classification by digital spiral analysis in a large population sample
Mr. Asanao Shimokawa
Associate Professor
Tokyo University of Science, Japan
P-B04-23 | Construction of decision tree using prior information
Mr. Thomas Stojanov
University Hospital Basel, Switzerland
P-B04-24 | Development and validation of a model predicting post-operative shoulder stiffness by patients undergoing an arthroscopic rotator cuff repair in Switzerland
Dr. Cristian Tebe
Germans Trias I Pujol Research Institute and Hospital (IGTP), Barcelona, Spain
P-B04-25 | Can a clinical model be used to update a radiomics deep learning model for prediction of lung nodule malignancy?
Dr. David Van Klaveren
Associate Professor
Erasmus MC, Rotterdam, Netherlands
P-B04-26 | Stronger penalties on treatment-covariate interactions improve the ability to predict treatment effect
Mr. Steven Wambua
University of Birmingham, United Kingdom
P-B04-27 | Development and validation of postpartum cardiovascular disease (CVD) risk prediction model in women with a history of pregnancy incorporating reproductive and pregnancy-related candidate predictors.
Dr. Junfeng Wang
Assistant Professor
Utrecht University, Netherlands
P-B04-28 | Comparison of different strategies in using Lasso in clinical prediction models for rare outcomes: A simulation study
Mr. Zhenwei Yang
Erasmus MC, Rotterdam, Netherlands
P-B04-29 | Predictive accuracy metrics in the context of interval censoring and competing risks
Ms. Lucinda Archer
University of Birmingham, United Kingdom
P-B04-30 | Stop before you start: A checklist for those thinking about developing a clinical prediction model
Ms. Lucinda Archer
University of Birmingham, United Kingdom
P-B04-31 LB | Uncertainty in clinical risk prediction: perspectives and approaches
Dr. Amardeep Legha
Research Fellow In Biostatistics
University of Birmingham, United Kingdom